BioSpace News Archive

Genetown

Enveric Biosciences Initiates GLP Toxicology & Safety Pharmacology Studies for Lead Candidate EB-373, a Next Generation Psilocin Prodrug Targeting Psychiatric Disorders

Key preclinical milestone designed to establish safety profile and maximum tolerated dose for anticipated clinical trial of EB-373.

October 18, 2023
·
5 min read
Biotech Beach

Ensysce Biosciences Announces Poster Presentation at the AAPS 2023 PharmSci 360

Ensysce Biosciences, Inc. today announced Dr. Dolly Jacob, Director Integrated Development Services of Quotient Sciences, will present the collaborative work of Ensysce and Quotient Sciences in a poster.

October 18, 2023
·
4 min read
Biotech Bay

Spruce Biosciences Completes Target Enrollment of CAHmelia-203 Study in Adult Classic Congenital Adrenal Hyperplasia

Spruce Biosciences, Inc. today announced completion of target enrollment of 72 patients and closure of screening in the CAHmelia-203 clinical trial evaluating tildacerfont for the treatment of adult classic congenital adrenal hyperplasia (CAH) and provided updated anticipated milestones.

October 18, 2023
·
11 min read
Genetown

Yield10 Bioscience Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research

Yield10 Bioscience, Inc. today announced that the Company has exercised its option to finalize an exclusive global, commercial license to advanced omega-3 production technology from U.K.

October 18, 2023
·
6 min read
GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment

Genetic Technologies Limited, a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the publication of a peer-reviewed research paper validating geneType’s Pancreatic Cancer risk assessment test.

October 18, 2023
·
3 min read
Biotech Bay

Napo Pharmaceuticals to Exhibit at the October 25-28 Annual Association of Nurses in AIDS Care (ANAC) Conference for Mytesi, the Company’s FDA-Approved Prescription Drug

Napo Pharmaceuticals (Napo), a Jaguar Health, Inc. (NASDAQ:JAGX) family company, today announced that it will exhibit at the Annual Association of Nurses in AIDS Care (ANAC) Conference.

October 18, 2023
·
5 min read
Policy

Celularity Announces Commercial Biomaterial Products Receive Saudi Food and Drug Authority (SFDA) Product Classification

Celularity Inc. announced that its Halal Certified biomaterial products have been classified by the Saudi Food and Drug Authority as “Minimally Manipulated Biological Products” for importation license purposes in the Kingdom of Saudi Arabia.

October 18, 2023
·
5 min read
BriaCell Announces Presentations at the 2023 Society for the Immunotherapy of Cancer (SITC) and San Antonio Breast Cancer (SABC) Conferences

BriaCell Therapeutics Corp. will be presenting at the following two upcoming scientific conferences.

October 18, 2023
·
3 min read
Business

Together for CHANGE Genomics and Equity Initiative Launched by a Coalition of Meharry Medical College, Regeneron Genetics Center, AstraZeneca, Novo Nordisk, and Roche to Improve Health Outcomes for People of African Ancestry

Meharry Medical College, along with partners Regeneron Genetics Center®, AstraZeneca, Novo Nordisk, and Roche, announced the launch of the Together for CHANGE™ initiative to create better health care and outcomes for all.

October 18, 2023
·
11 min read
Biotech Bay

Actym Closes $59.5 Million Series A with New $25.5 Million Extension

Actym Therapeutics adds $25.5 million to close its Series A with $59.5 million total New investor GKCC LLC joins syndicate Capital will propel lead program ACTM-838 into first-in-human oncology trial and further advance proprietary STACT platform.

October 18, 2023
·
3 min read